High-tech enterprises in Zhongguancun

Since its establishment, Zhongguancun Medical Engineering Transformation Center has been actively providing domestic and foreign Chinese medicine, biomedicine, and medical device enterprises at different stages of development with integrated services of scientific and technological innovation and entrepreneurship chain, and helping them to realize comprehensive breakthroughs and enter into a benign, healthy and sustainable development track by leading the way from point to point. A few days ago, Beijing Science and Technology Commission and Zhongguancun Science and Technology Park Management Committee released the Zhongguancun Hi-Tech Enterprise Database (as of January 2022) and the 2021 Gazelle Enterprise List on their websites.

In the Zhongguancun National Innovation Demonstration Zone, 7 enterprises introduced and served by the Zhongguancun Medical Engineering Transformation Center (ZMETC) entered the Zhongguancun Hi-Tech Enterprise Database, and 3 of them

entered the list of Gazelle Enterprises at the same time.

This time, 25,406 enterprises entered the Zhongguancun Hi-Tech Enterprise Database, involving 11 fields such as electronics and information, advanced manufacturing technology, bio-engineering and new pharmaceuticals, among which 2,046 enterprises are in the category of advanced manufacturing technology, and 1,755 enterprises are in the category of bio-engineering and new pharmaceuticals. There are 6 bio-engineering and new medicine enterprises and 1 advanced manufacturing technology enterprise in the enterprises introduced and served by the Transformation Center.

Zhongguancun High-tech Enterprises Pool List and their Technology Fields (only including enterprises introduced and served by the Transformation Center)

Zhongguancun High-tech Enterprises refer to those enterprises that have formed core intellectual property rights through continuous research and development and transformation of technological achievements in the high-tech fields that are supported by the State in the Zhongguancun Science and Technology Park, and carry out business activities based on them to turn significant high-tech achievements into productivity, and to make their products and services more efficient and effective. Through continuous research and development and technological achievements transformation, the core independent intellectual property of the enterprise is formed, and operation activities are carried out on the basis of this, and the major high-tech achievements are transformed into productive forces, which are domestic or international advanced enterprises.

The Zhongguancun High-tech Enterprise Certification is issued by the Management Committee of Beijing Zhongguancun Science and Technology Park, which has a series of strict requirements on the qualification, scientific and technological research and development strength, profitability and development ability of the declared enterprises, and has a strict certification process.

Gazelle enterprises

Previously, the Beijing Science and Technology Commission, Zhongguancun Science and Technology Park Management Committee website also announced the 2021 gazelle enterprise list,*** 5629 enterprises were shortlisted. Among them, the enterprises introduced by the Transformation Center -

Beijing Huada Jibi Ai Biotechnology Co.

Gazelle enterprises include "Gazelle Program" enterprises, gazelle key cultivation of two types of enterprises.

In order to improve the financing environment for small and medium-sized high-tech enterprises in Zhongguancun Science Park, the Administrative Committee of Zhongguancun Science Park formulated the "Gazelle Program" and the "Several Financial Measures on Supporting the Development of Gazelle Key Cultivation Enterprises in Zhongguancun National Innovation Demonstration Zone (Revised)", which are evaluated based on certain criteria. The "Gazelle Program" and the "Gazelle Key Cultivation Enterprises" are evaluated based on certain criteria, and certain preferential measures are given to the selected enterprises.

Zhongguancun International Pharmaceutical Inspection and Certification Technology Co., Ltd

Founded in 2015, Zhongguancun International Pharmaceutical Inspection and Certification Technology Co., Ltd

is a national high-tech enterprise that focuses on the inspection and testing of sterilized products, food, cosmetic products, water quality, and water-related products and other health-related fields.

The company is headquartered in Beijing and has set up wholly-owned branches in Chongqing and Fujian, with more than 5,000 items of testing capacity certified by CMA and more than 600 items of testing capacity certified by CNAS. We have achieved full coverage of disinfection product testing items and more than 98% of food safety sampling items by the State Administration of Market Supervision.

Watson Creek (Beijing) Biotechnology Co., Ltd

Founded in 2015, Watson Creek is a national high-tech biotechnology group company engaged in the rapid development of life banking and cellular health care. The company has obtained the double recognition of national high-tech enterprise and Zhongguancun high-tech enterprise, is the pilot unit of Beijing patent, its gene technology, sample bank technology, cell technology at the same time to obtain the ISO9001-2015 international quality system certification, is the key laboratory of Zhongguancun Medical Translation Center and the Beijing regional cell preparation center, the China Association of Pharmaceutical Biotechnology, the China Association of Skin Soft Tissue Repair, and the China Association of Pharmaceutical Biotechnology. It is the key laboratory of Zhongguancun Medical Translation Center and Beijing Regional Cell Preparation Center, the member unit of China Association of Pharmaceutical Biotechnology, and the director unit of China Skin and Soft Tissue Repair and Reconstruction Technology Committee.

Beijing Huada Jibi Ai Biotechnology Co., Ltd

Founded in 1994, as a core subsidiary of Shenzhen Huada Genetics Co., Ltd, the company is mainly engaged in the research and development of in vitro diagnostic reagents, production, sales and provision of medical testing solutions, and is the first batch of in vitro diagnostic reagent enterprises to pass the GMP certification. The blood screening products have been 100% approved by the State Drug Administration for more than 20 consecutive years, and have topped the national clinical quality assessment organized by the Chinese Center for Disease Control and Prevention (CDC) for many times with perfect scores.

The company now has enzyme immunoassay, chemiluminescence, nucleic acid detection, POCT, mass spectrometry, clinical examination services, biochip joint detection, biochemical testing, gene sequencing and other technology platforms, covering fertility, tumor screening and medication guidance, common diseases, infectious diseases, blood screening, nutrition and metabolism product lines, is one of the IVD companies with a complete platform in the country.

Beijing Jieya Leifu Biotechnology Co., Ltd

Founded in 1995, Beijing Jieya Leifu Biotechnology Co., Ltd

is one of the first high-tech enterprises in China to engage in the development, production and sales of bio-tissue engineering products. It owns the international level of tissue engineering patent technology. The main products are: J-1 type decellularized allogeneic dermis, human biological dressings, human soft tissue repair materials and newly developed bone repair materials and other series of products.

Beijing SALTECH Biomedical Technology Co., Ltd

is located in Zhongguancun Science Park Park Beida Science and Technology Park, belongs to the National High-tech Enterprise, Zhongguancun High-tech Enterprise, Haidian District Innovative Enterprises. Founded on July 19, 2006, the company has been engaged in the research and development of autologous cell therapy technology and tissue engineering technology and products, and has applied the tissue engineering therapy technology and autologous cell therapy technology to the clinic, and currently owns 7 patents, which belong to the field of tissue engineering and genetic engineering. Through the cooperation with domestic universities and U.S. universities, the company has developed three tissue engineering technologies and clinical applications: autologous skin cell repair treatment technology, autologous corneal epithelium treatment technology, tissue engineering composite skin treatment technology. The company's research and development technologies and products mainly include: neural stem cell therapy products, animal vaccine adjuvant development, gene drug development projects.

Beijing Watson Baio Biotechnology Research Institute Co., Ltd

Founded on March 05, 2018, the scope of business includes technology development, technology transfer, technical services, technical consulting of stem cell gene drugs; medical research and experimental development; sales of medical devices Class I; Chinese medicine medical services.

Beijing Lifespectrum Biotechnology Co Ltd

was established on March 09, 2018, the scope of business includes the sale of self-developed products, cosmetics, chemical products (excluding hazardous chemicals and a class of perishable chemicals); medical research and experimental development; health consulting, health management (subject to approval of diagnostic and therapeutic activities, except).